These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 15333652)

  • 21. Expression of CDX2, cytokeratins 7 and 20 in sinonasal intestinal-type adenocarcinoma.
    Ortiz-Rey JA; Alvarez C; San Miguel P; Iglesias B; Antón I
    Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):142-6. PubMed ID: 15894926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases.
    Vang R; Gown AM; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM
    Am J Surg Pathol; 2006 Sep; 30(9):1130-9. PubMed ID: 16931958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas: an immunohistochemical study of 22 cases utilizing CDX2 and MUC2.
    Cathro HP; Mills SE
    Am J Surg Pathol; 2004 Aug; 28(8):1026-32. PubMed ID: 15252308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries.
    Groisman GM; Meir A; Sabo E
    Int J Gynecol Pathol; 2004 Jan; 23(1):52-7. PubMed ID: 14668551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine.
    Chen ZM; Wang HL
    Am J Surg Pathol; 2004 Oct; 28(10):1352-9. PubMed ID: 15371952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases.
    Nonaka D; Kusamura S; Baratti D; Casali P; Younan R; Deraco M
    Histopathology; 2006 Oct; 49(4):381-7. PubMed ID: 16978201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-grade nonintestinal sinonasal adenocarcinoma: a diagnosis of exclusion.
    Bhaijee F; Carron J; Bell D
    Ann Diagn Pathol; 2011 Jun; 15(3):181-4. PubMed ID: 21393036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary.
    Rabban JT; Lerwill MF; McCluggage WG; Grenert JP; Zaloudek CJ
    Int J Gynecol Pathol; 2009 Jan; 28(1):41-8. PubMed ID: 19047909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
    Bayrak R; Haltas H; Yenidunya S
    Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies.
    Goldstein NS; Thomas M
    Am J Clin Pathol; 2001 Sep; 116(3):319-25. PubMed ID: 11554157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas.
    Tot T
    Cancer; 2001 Nov; 92(10):2727-32. PubMed ID: 11745209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDX-2 expression is a common event in primary intestinal-type endocervical adenocarcinoma.
    Saad RS; Ismiil N; Dubé V; Nofech-Mozes S; Khalifa MA
    Am J Clin Pathol; 2009 Oct; 132(4):531-8. PubMed ID: 19762530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal metaplasia of the sinonasal mucosa adjacent to intestinal-type adenocarcinoma. A morphologic, immunohistochemical, and molecular study.
    Franchi A; Palomba A; Miligi L; Ranucci V; Innocenti DR; Simoni A; Pepi M; Santucci M
    Virchows Arch; 2015 Feb; 466(2):161-8. PubMed ID: 25431194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Value of cytokeratin 7 and 20 for the diagnosis of cerebral metastases of adenocarcinoma: study of 78 cases].
    Fernandez C; Liprandi A; Bouvier-Labit C; Figarella-Branger D
    Ann Pathol; 2001 Apr; 21(2):129-35. PubMed ID: 11373582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma.
    Su YC; Hsu YC; Chai CY
    Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores.
    Goldstein NS
    Am J Clin Pathol; 2002 Mar; 117(3):471-7. PubMed ID: 11888088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].
    Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoprofile of adenocarcinomas of the endometrium, endocervix, and ovary with mucinous differentiation.
    Park KJ; Bramlage MP; Ellenson LH; Pirog EC
    Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):8-11. PubMed ID: 18776815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
    Shin JH; Bae JH; Lee A; Jung CK; Yim HW; Park JS; Lee KY
    Jpn J Clin Oncol; 2010 Mar; 40(3):208-13. PubMed ID: 19926591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.